These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 22512637

  • 1. IL-13 receptor-directed cancer vaccines and immunotherapy.
    Nakashima H, Husain SR, Puri RK.
    Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
    [Abstract] [Full Text] [Related]

  • 2. A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models.
    Nakashima H, Terabe M, Berzofsky JA, Husain SR, Puri RK.
    J Immunol; 2011 Nov 15; 187(10):4935-46. PubMed ID: 22013118
    [Abstract] [Full Text] [Related]

  • 3. A Novel Recombinant Modified Vaccinia Ankara Virus expressing Interleukin-13 Receptor α2 Antigen for Potential Cancer Immunotherapy.
    Sato Y, Vatsan R, Joshi BH, Husain SR, Puri RK.
    Curr Mol Med; 2024 Nov 15; 24(6):758-770. PubMed ID: 36999709
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DNA vaccine for cancer immunotherapy.
    Yang B, Jeang J, Yang A, Wu TC, Hung CF.
    Hum Vaccin Immunother; 2014 Nov 15; 10(11):3153-64. PubMed ID: 25625927
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2.
    Mintz A, Gibo DM, Madhankumar AB, Cladel NM, Christensen ND, Debinski W.
    Cancer Biother Radiopharm; 2008 Oct 15; 23(5):581-9. PubMed ID: 18976118
    [Abstract] [Full Text] [Related]

  • 12. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.
    Immunol Rev; 2008 Apr 15; 222():316-27. PubMed ID: 18364011
    [Abstract] [Full Text] [Related]

  • 13. Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy.
    Knudson KM, Hwang S, McCann MS, Joshi BH, Husain SR, Puri RK.
    Front Immunol; 2022 Apr 15; 13():878365. PubMed ID: 35464460
    [Abstract] [Full Text] [Related]

  • 14. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1996 Apr 15; 16(2):661-74. PubMed ID: 8687112
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cancer vaccines. Any future?
    Myc LA, Gamian A, Myc A.
    Arch Immunol Ther Exp (Warsz); 2011 Aug 15; 59(4):249-59. PubMed ID: 21644030
    [Abstract] [Full Text] [Related]

  • 17. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D, Appel S.
    Scand J Immunol; 2013 Aug 15; 78(2):167-71. PubMed ID: 23672402
    [Abstract] [Full Text] [Related]

  • 18. Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.
    Bodey B, Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 2000 Aug 15; 20(4):2665-76. PubMed ID: 10953341
    [Abstract] [Full Text] [Related]

  • 19. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
    Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu D.
    Immunol Rev; 2004 Jun 15; 199():156-80. PubMed ID: 15233733
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.